Alzamend Neuro, Inc.
ALZN
$2.96
-$0.03-1.00%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.95M | 3.36M | 4.09M | 1.19M | 376.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 228.70K | 589.20K | 673.70K | 222.20K | 79.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.18M | 3.95M | 4.77M | 1.42M | 455.20K |
|
|
|||||
| Total Current Assets | 4.18M | 3.95M | 4.77M | 1.42M | 455.20K |
| Net Property, Plant & Equipment | 425.60K | 228.30K | 241.00K | 253.70K | 176.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.60M | 4.18M | 5.01M | 1.67M | 631.60K |
|
|
|||||
| Total Accounts Payable | 634.80K | 725.90K | 1.25M | 2.88M | 2.93M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 300.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 634.80K | 725.90K | 1.25M | 2.88M | 3.23M |
|
|
|||||
| Total Current Liabilities | 634.80K | 725.90K | 1.25M | 2.88M | 3.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 300.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 634.80K | 725.90K | 1.25M | 2.88M | 3.23M |
|
|
|||||
| Common Stock & APIC | 62.50M | 60.85M | 60.16M | 53.78M | 51.43M |
| Retained Earnings | -58.54M | -57.40M | -56.41M | -54.99M | -54.02M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.97M | 3.45M | 3.75M | -1.21M | -2.59M |
|
|
|||||